The past 5–10 years have brought in a new era in the care of patients with thyroid cancer,
with the introduction of transformative diagnostic and management options. Several …

For thyroid cancer clinical trials, the inclusion of participants from diverse patient populations
is uniquely important given existing racial/ethnic disparities in thyroid cancer care. Since …

PURPOSE Thyroid autoimmunity has been associated with differentiated thyroid cancer
although multiple potential biases might have influenced the results of previous studies …

Abstract Background The 2015 American Thyroid Association (ATA) guidelines reduced the
recommended extent of therapy for low-risk thyroid cancers. Little is known about the impact …

ABSTRACT Purpose Asians and/or Pacific Islanders (APIs) are at high risk of thyroid cancer,
hence we examined thyroid cancer's incidence among disaggregated API subgroups in the …

Introduction Prior studies have demonstrated insurance-based disparities in the treatment of
well-differentiated thyroid cancer. However, it remains unclear whether these disparities …

Background: Health insurance has been shown to be a key determinant in cancer care, but it
is unknown as to what extent insurance status affects treatments provided to papillary thyroid …

Background Disparities have been previously described in the presentation, management,
and outcomes of other thyroid cancer subtypes; however, it is unclear whether such …

Context Little is known about provider specialties involved in thyroid cancer diagnosis and
management. Objective Characterize providers involved in diagnosing and treating thyroid …

Research suggests that thyroid cancer incidence rates are increasing, and environmental
exposures have been postulated to be playing a role. To explore this possibility, we …